Publikationen von C. W. Turck

Otte, D. M.; Sommersberg, B.; Kudin, A.; Guerrero, C.; Albayram, O.; Filiou, M. D.; Frisch, P.; Yilmaz, O.; Drews, E.; Turck, C. W. et al.; Bilkei-Gorzo, A.; Kunz, W. S.; Beck, H.; Zimmer, A.: N-acetyl Cysteine Treatment Rescues Cognitive Deficits Induced by Mitochondrial Dysfunction in G72/G30 Transgenic Mice. Neuropsychopharmacology 36 (11), S. 2233 - 2243 (2011)

Filiou, M. D.; Teplytska, L.; Gormanns, P.; Reckow, S.; Zhang, Y.; Frank, E.; Kessler, M. S.; Nussbaumer, M.; Maccarrone, G.; Landgraf, R. et al.; Turck, C. W.: Anxiety and mitochondria: Insights from the -omics world. Pharmacopsychiatry 44 (6), S. 289 - 289 (2011)

Filiou, M. D.; Teplytska, L.; Otte, D. M.; Yilmaz, O.; Zimmer, A.; Turck, C. W.: Proteomic alterations in G72/G30 transgenic mice. Pharmacopsychiatry 44 (6), S. 289 - 289 (2011)

Maccarrone, G.; Nischwitz, S.; Deininger, S. O.; Hornung, J.; König, F. B.; Stadelmann, C.; Turck, C. W.; Weber, F.: MALDI imaging - a new tool for mapping multiple sclerosis brain lesions. Pharmacopsychiatry 44 (6), S. 300 - 300 (2011)

Varadarajulu, J.; Lebar, M.; Krishnamoorthy, G.; Habelt, S.; Lu, J.; Weinstein, I. B.; Li, H. Y.; Holsboer, F.; Turck, C. W.; Touma, C.: Increased anxiety-related behaviour in Hint1 knockout mice. Behavioural Brain Research 220 (2), S. 305 - 311 (2011)

Gormanns, P.; Mueller, N. S.; Ditzen, C.; Wolf, S.; Holsboer, F.; Turck, C. W.: Phenome-transcriptome correlation unravels anxiety and depression related pathways. Journal of Psychiatric Research 45 (7), S. 973 - 979 (2011)

Tretter, F.; Gebicke-Haerter, P. J.; Heiden, U. A. D.; Rujescu, D.; Mewes, H. W.; Turck, C. W.: Affective Disorders as Complex Dynamic Diseases - a Perspective from Systems Biology. Pharmacopsychiatry 44 (Suppl. 1), S. S2 - S8 (2011)

Tretter, F.; Rujescu, D.; Turck, C. W.; Mewes, H. W.: Editorial. Pharmacopsychiatry 44 (Suppl. 1), S. S1 - S1 (2011)

Turck, C. W.; Iris, F.: Proteome-Based Pathway Modelling of Psychiatric Disorders. Pharmacopsychiatry 44 (Suppl. 1), S. S54 - S61 (2011)

Friedman, D. B.; Andacht, T. M.; Bunger, M. K.; Chien, A. S.; Hawke, D. H.; Krijgsveld, J.; Lane, W. S.; Lilley, K. S.; MacCoss, M. J.; Moritz, R. L. et al.; Settlage, R. E.; Sherman, N. E.; Weintraub, S. T.; Witkowska, H. E.; Yates, N. A.; Turck, C. W.: The ABRF Proteomics Research Group Studies: Educational exercises for qualitative and quantitative proteomic analyses. Proteomics 11 (8), S. 1371 - 1381 (2011)

Martins-de-Souza, D.; Lebar, M.; Turck, C. W.: Proteome analyses of cultured astrocytes treated with MK-801 and clozapine: similarities with schizophrenia. European Archives of Psychiatry and Clinical Neuroscience 261 (3), S. 217 - 228 (2011)

Turck, C. W.; Landgraf, R.; Filiou, M. D.; Zhang, Y.; Webhofer, C.; Reckow, S.; Gormanns, P.; Ditzen, C.; Maccarrone, G.; Varadarajulu, J.: Biomarkers for anxiety disorders: proteomic and systems biology approaches. European Neuropsychopharmacology 21 (Suppl. 2), S. S110 - S111 (2011)

Martins-de-Souza, D.; Gattaz, W. F.; Schmitt, A.; Maccarrone, G.; Falkai, P.; Bahn, S.; Dias-Neto, E.; Turck, C. W.: What does proteomics tell us about schizophrenia. Schizophrenia Bulletin 37 (Suppl. 1), S. 116 - 117 (2011)

Zhang, Y. Y.; Reckow, S.; Webhofer, C.; Boehme, M.; Gormanns, P.; Egge-Jacobsen, W. M.; Turck, C. W.: Proteome Scale Turnover Analysis in Live Animals Using Stable Isotope Metabolic Labeling. Analytical Chemistry 83 (5), S. 1665 - 1672 (2011)

Bonfiglio, J. J.; Maccarrone, G.; Rewerts, C.; Holsboer, F.; Arzt, E.; Turck, C. W.; Silberstein, S.: Characterization of the B-Raf interactome in mouse hippocampal neuronal cells. Journal of Proteomics 74 (2), S. 186 - 198 (2011)

Filiou, M. D.; Turck, C. W.; Martins-de-Souza, D.: Quantitative proteomics for investigating psychiatric disorders. Proteomics Clinical Applications 5 (1-2), S. 38 - 49 (2011)

Martins-de-Souza, D.; Gattaz, W. F.; Schmitt, A.; Maccarrone, G.; Hunyadi-Gulyas, E.; Eberlin, M. N.; Souza, G. H. M. F.; Marangoni, S.; Novello, J. C.; Turck, C. W. et al.; Dias-Neto, E.: Proteomic analysis of dorsolateral prefrontal cortex indicates the involvement of cytoskeleton, oligodendrocyte, energy metabolism and new potential markers in schizophrenia (vol 43, pg 978, 2009). Journal of Psychiatric Research 45 (2), S. 283 - 283 (2011)

Filiou, M. D.; Turck, C. W.: General Overview: Biomarkers In Neuroscience Research. Biomarkers of Neurological and Psychiatric Disease, S. 1 - 17 (2011)

Schmidt, M. V.; Schülke, J.-P.; Liebl, C.; Stiess, M.; Avrabos, C.; Bock, J.; Wochnik, G. M.; Davies, H. A.; Zimmermann, N.; Scharf, S. H. et al.; Trümbach, D.; Wurst, W.; Zieglgänsberger, W.; Turck, C.; Holsboer, F.; Stewart, M. G.; Bradke, F.; Eder, M.; Müller, M. B.; Rein, T.: Tumor suppressor down-regulated in renal cell carcinoma 1 (DRR 1) is a stress-induced actin bundling factor that modulates synaptic efficacy and cognition. Proceedings of the National Academy of Sciences of the United States of America 108 (41), S. 17213 - 17218 (2011)

Martins-de-Souza, D.; Maccarrone, G.; Wobrock, T.; Zerr, I.; Gormanns, P.; Reckow, S.; Falkai, P.; Schmitt, A.; Turck, C. W.: Proteome analysis of the thalamus and cerebrospinal fluid reveals glycolysis dysfunction and potential biomarkers candidates for schizophrenia. Journal of Psychiatric Research 44 (16), S. 1176 - 1189 (2010)